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Abstract
Background: MicroRNAs (miRNAs) are 18–23 nucleotide non-coding RNAs that regulate gene expression in a sequence
specific manner. Little is known about the repertoire and function of miRNAs in melanoma or the melanocytic lineage. We
therefore undertook a comprehensive analysis of the miRNAome in a diverse range of pigment cells including:
melanoblasts, melanocytes, congenital nevocytes, acral, mucosal, cutaneous and uveal melanoma cells.
Methodology/Principal Findings: We sequenced 12 small RNA libraries using Illumina’s Genome Analyzer II platform. This
massively parallel sequencing approach of a diverse set of melanoma and pigment cell libraries revealed a total of 539
known mature and mature-star sequences, along with the prediction of 279 novel miRNA candidates, of which 109 were
common to 2 or more libraries and 3 were present in all libraries.
Conclusions/Significance: Some of the novel candidate miRNAs may be specific to the melanocytic lineage and as such
could be used as biomarkers to assist in the early detection of distant metastases by measuring the circulating levels in
blood. Follow up studies of the functional roles of these pigment cell miRNAs and the identification of the targets should
shed further light on the development and progression of melanoma.
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Introduction
Small (18–23 nucleotide) non-coding RNAs called microRNAs
(miRNAs) have been shown to regulate gene expression in a
sequence specific manner. Originally this was thought to be
accomplished solely through binding to the 39 UTR of target
mRNAs and either targeting the transcripts for degradation or
blocking translation of the encoded protein, however, it is now
evident that miRNAs can also stimulate translation [1] and
regulate transcription through binding to gene promoters [2].
MiRNAs are thus central regulators of gene expression and can act
both in a positive and negative way to control protein levels in the
cell. MiRNA expression is generally down-regulated in cancer [3]
and this appears to be due to defects in the processing of the
immature primary miRNA transcripts (pri-miRNAs) to precursor
miRNA transcripts (pre-miRNAs) by the enzyme Drosha [4]. The
pre-miRNA stem-loop has the possibility of producing two mature
miRNAs, one from the plus strand and one from the minus strand
(miRNA*). Following cleavage by Drosha, pre-miRNAs are
exported from the nucleus into the cytoplasm by Exportin 5
where these hairpin precursors are cleaved by Dicer into small,
imperfect dsRNA duplexes (miRNA: miRNA
*) that contains both
the mature miRNA strand and its complementary strand
(miRNA
*) (reviewed in [5]). In most cases the miRNA* sequence
is degraded leaving the mature sequence to be incorporated into
the RISC complex and target mRNAs in a sequence-specific
manner through the RNA interference pathway [5]. In cancer,
particular miRNAs have been shown to be oncogenic [6,7,8], or
conversely, tumor suppressive [9,10].
Given their role in modulating gene expression it is not
surprising that miRNAs have been shown to be intimately
involved in regulating a wide variety of biological processes,
including proliferation, apoptosis, cell-cycle control, and differen-
tiation. In particular, miR-221 and miR-222 have been reported
to regulate melanoma progression through p27 [11]. One of the
most oncogenic miRNAs, miR-21 [12], has been shown to be
involved in invasion and metastasis in many cancer types by its
action on numerous genes involved in extracellular matrix
modification, in particular PTEN (reviewed in [13]), a tumor
suppressor gene involved in melanoma etiology [14].
Little is known about the repertoire and function of miRNAs in
melanoma. A handful of studies have assessed the levels of subsets
PLoS ONE | www.plosone.org 1 March 2010 | Volume 5 | Issue 3 | e9685of miRNAs through microarray expression profiling [15,16] or
have assessed the mechanisms of action of select miRNAs in this
tumor type [11,17,18,19].
A greater understanding of the roles of individual miRNAs in
melanoma development requires comprehensive analysis of the
full complement of such molecules and their relative abundance.
We thus set out to extend the repertoire of miRNAs in a diverse
range of normal and malignant pigment cells through deep
sequencing. We constructed 12 small RNA libraries from cell
cultures of melanoblasts, melanocytes and nevocytes, as well as
acral, mucosal, cutaneous and uveal melanomas. Using a series of
bioinformatics tools we quantified known mature miRNA
sequences and predicted novel miRNA candidates.
Results
Overview
Each library was sequenced independently. Figure 1 shows a
flowchart representing the steps involved to annotate known
microRNAs and the discovery of the predicted candidate
microRNAs using miRanalyzer [20] and CID-miRNA [21].
Briefly, between 1.5–6.5 million total sequence reads were
obtained for a given library and this ranged from 1.2–5.8 million
reads whose sequences were present at least twice. The number of
perfect matches for these reads that aligned to the human genome
(hg18) ranged from 1.1–5.1 million. Using miRanalyzer, all of the
unique sequence counts were aligned to the known pre-miRNA
sequences (miRBase v12, September 2008). These reads ranged
from 875K–4.1 million which generated at total of 539 unique
known miRNAs present in one or more libraries. To identify novel
candidate miRNAs the miRanalyzer program was used to remove
the known miRNAs from the pool, with the remainder then
aligned to the hg18 transcriptome (142K–1.5 million reads) in
order to filter out any potentially degraded mRNA sequences.
These were then also removed from the pool. All sequence reads
that passed this filtering process were then mapped to the human
genome with 895–9800 reads, per library with features of
predicted novel miRNAs. For each of these candidates the
surrounding sequence was assessed to determine if it was able to
form a hairpin structure using the Vienna RNAfold package [22],
indicative of a pre-miRNA. Sequences that met this criterion were
deemed to be novel candidate miRNAs (combined total of 722
predicted candidates across all libraries) These predicted novel
miRNAs were filtered further using CID-miRNA [21] (for details
see section ‘‘Novel miRNAs’’ below). This reduced the list to 279
novel candidate miRNAs which have a high likelihood of being
bona fide miRNAs. Identical reads were tallied to determine their
fraction amongst all unique sequence tags for each library. Both
Figure 1. Flowchart representing the steps involved to annotate known microRNAs and the discovery of predicted candidate
microRNAs using miRanalyzer [20] and CID-miRNA [21]. White boxes represent the range of numbers for an individual library. Green boxes
represent the total number of unique miRNAs across all libraries. Blue boxes represent unmatched reads which were not considered further.
doi:10.1371/journal.pone.0009685.g001
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considerably between libraries, as shown in the summary statistics
(a detailed description of which can be found in Hackenberg et al.
[20]) for each small RNA library presented in Tables S1A-S1L. All
counts and predictions were generated using the miRanalyzer web
server tool [20].
The melanoblast library (QF1160MB) had the highest number
of unique sequence tags (77,261) and the melanocyte library
(MELB) had the fewest (17,809) (Tables S1A and S1B respectively).
Known mature and mature-star miRNAs
There are 847 human mature and mature-star miRNAs
annotated in release 12.0 of miRBase (Sept 2008) [23]. The
relative proportion of each of these was determined for each
library (Table S1). A total of 539 mature and mature-star
sequences (Table S2) were found across the 12 small RNA
libraries. The total number in each library varied from 280 (D10)
up to 374 (D20), with 180 sequences being common to all libraries
(Table S3).
Hsa-let7f had the highest expression in all libraries, with the
exception of MM466, where hsa-miR-29a was the highest. Table 1
shows the top 10 most abundant miRNAs in each library, which
overall are represented by a non-redundant list of 23 miRNAs. A
total of 96 miRNAs were found to be present in only a single
library (Table S4).
The relative ratios of miRNA to miRNA* sequence reads
ranged from 0.03:1 to 242,000:1 (Table S5). A total of 23 miRNAs
were found to have roughly equivalent (0.75–2.2 relative ratio)
counts generated from each arm of the pre-miRNA in at least one
of the libraries (Table S5). However, 21 mature-star miRNAs were
actually more abundant (0.01–0.74 relative ratio) than the
corresponding mature sequences (Table S5). The remainder of
the mature/mature-star miRNA ratios showed that the mature
sequence was more highly expressed in the majority of the libraries
(Table S5).
We observed heterogeneity in the start and end positions of the
sequence tags. In all libraries, we noted a high proportion of
sequence tags that showed variation from their mature reference
sequence. These variable length miRNAs are termed ‘isomirs’.
Figure 2 shows an example of a mature miRNA that differs at both
the 59 and 39 ends. For the known miRNAs sequenced in the
melanoma libraries, 39 heterogeneity occurred more commonly
than 59 heterogeneity. This is in keeping with findings from other
miRNA deep sequencing studies (e.g. [24] and references therein).
Of the 847 human miRNAs annotated, we found a total of 220
hairpin regions of the pre-miRNA that were present in at least one
of the libraries (Table S6). Five of these had relatively high
expression levels (hsa-mir-320a, hsa-mir-1826, hsa-mir-1307, hsa-
mir-29a and hsa-mir-423).
Novel miRNAs
A total of 722 novel miRNA candidates were identified in a
step-wise fashion using miRanalyzer [20] (Table S7). Firstly all of
the unique sequence counts were aligned to the known pre-
miRNA sequences (miRBase v12, September 2008). These
sequences were then removed from the pool. The remainder
were aligned to the hg18 transcriptome. The sequences that
aligned to the transcriptome were also removed from the pool. All
Table 1. Rank order of the top 10 most common miRNAs in each library.
miRNA name QF1160MB MELB MM653 D20 MM386 MM426 MM466 MM603 MM472 D10 D11 MEL202
hsa-let-7a 2 2 1 2 123222 2 2
hsa-let-7b 5 3 2 3 5 3 4 3 4 5 5
hsa-let-7d 9 8 6 7 7
hsa-let-7e 6 4 8 9
hsa-let-7f 1 1 3 1 317111 1 1
hsa-let-7g 10 10 7 4 8
hsa-let-7i 3 5 10 6 6 9 8 6
hsa-miR-103 10 8 76236 3 6
hsa-miR-140-3p 49 9 1 0
hsa-miR-146a 8
hsa-miR-181a 10
hsa-miR-185 10
hsa-miR-21 6 5 44895
hsa-miR-211 10
hsa-miR-221 4 7 9
hsa-miR-222 9
hsa-miR-25 9 10 10 8
hsa-miR-29a 9 6 7 4 251573
hsa-miR-320a 4 8 5 9 8 7 3
hsa-miR-378 7 7 10 7 4 5 4
hsa-miR-423-5p 8 8 5 10
hsa-miR-886-5p 6
hsa-miR-92a 96
doi:10.1371/journal.pone.0009685.t001
Melanoma miRNA Deep Sequencing
PLoS ONE | www.plosone.org 3 March 2010 | Volume 5 | Issue 3 | e9685sequence reads that passed this filtering process were then
mapped to the human genome. If the surrounding sequence
was able to form a hairpin structure using the Vienna RNAfold
package [22], indicative of a pre-miRNA, then the unique
sequence was deemed to be a novel candidate miRNA. These
predicted novel miRNA candidates were filtered further using
CID-miRNA [21]. This reduced the list to 389 novel candidate
miRNAs. RNAfold uses thermodynamic energy criteria to predict
a particular RNA secondary structure based on a minimum free
energy cut-off derived from thousands of experimentally mea-
sured thermodynamic parameters. The CID-miRNA program on
the other hand uses a probabilistic approach to ‘learn’ model
parameters from known miRNA datasets in an automated
fashion. The model is composed of grammar rules that describe
how a given sequence could be folded into a pre-miRNA stem
loop structure. A pre-miRNA secondary structure is made of
‘stem’ interrupted with‘symmetric’ and ‘asymmetric bulges’ and a
‘loop’ at the end. The stochastic context free grammar (SCFG)
rules were designed for each of those parts of the pre-miRNA
secondary structure. Each grammar rule has a probability
associated with it for generating a subsequence with potential to
make part of a secondary structure. A set of rules with maximum
probability are usediteratively togeneratea potentialpre-miRNA
sequence. Further filtering consisted of removing all mature
candidates that were most likely rRNA degradation products and
those that were found to lie in exons (.2 bp overhang into an
exon). This reduced the list to 279 which have a high likelihood of
being bona fide miRNAs. Table S7 shows all candidate
predictions including those that have been filtered out. The table
indicates which candidates have been assigned an official mirBase
name. Each candidate that was subsequently named had to meet
strict new criteria, specifically the abundance had to be .5r e a d s .
Table 2 shows the total number of unique and common novel
candidate miRNAs in each small RNA library. The relative
abundance of these in each of the libraries is given in Table S7.
The current version of miRBase (miRBase v13, March 2009) does
not list any of the novel human miRNAs found in our pigment cell
and melanoma libraries. In an effort to gain more confidence in
the prediction of the novel pre-miRNAs, we chose a candidate
from the high confidence list (MELmiRNA_677) that was selected
as it had sequence counts in all libraries. A custom Taqman assay
(Applied Biosystems) confirmed expression of MELmiRNA_677,
giving a Pearson’s correlation of 0.8 between the DCt value and
the relative proportion of sequence counts in each library (data
not shown).
Using the relative proportion of the total unique read counts
against total number of reads, a condition tree (Genespring 7.3.1,
Agilent) of all novel candidates plus known miRNAs gave good
separation of the different histological subtypes of sample
(Figure 3).
Mirtrons
Mirtrons are short introns with hairpin potential that can be
spliced and debranched into pre-miRNA hairpin structures, all of
which appear to bypass Drosha cleavage [25]. Typically, mirtrons
are anchored to splice sites both at the 59 and 39 ends [25]. While
we did not detect any ‘typical’ mirtrons, we did find 7 known
miRNAs classified as ‘atypical’ mirtrons, as described in [25] (i.e.
Figure 2. Example of a mature miRNA (hsa-mir-29a) showing variations in the 59 and 39 ends. The optimal secondary structure is
represented in dot-bracket notation (where brackets and full-stops represent complementary and non-complementary nucleotides respectively) with
the published mature miRNA bolded.
doi:10.1371/journal.pone.0009685.g002
Table 2. Total number of novel candidate miRNAs unique and common to each library.
QF1160MB MELB MM653 D20 MM386 MM426 MM466 MM603 MM472 D10 D11 MEL202
Unique to a
library
3 3 01 72 1 2 61 61 02 01 14 6 9
Present in 2
or more
libraries
52 16 33 51 64 39 45 40 33 22 27 25
Totals 85 16 50 72 90 55 55 60 44 26 33 34
doi:10.1371/journal.pone.0009685.t002
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8 atypical mirtrons not previously reported (Table S8). These
novel atypical mirtrons are in keeping with what is currently
submitted in mirBase (miRBase v13, March 2009). However,
submission of sequences to upcoming versions of mirBase require
adherence to very strict criteria imposed upon high-throughput
sequencing data. Some of which include the exclusion of all
mature candidates that are 16 nt in length and those that are
Figure 3. Unsupervised hierarchical clustering using the Pearson’s correlation between all expressed miRNAs. QF1160MB,
melanoblasts; MELB, melanocytes; D10, acral melanoma; D11, mucosal melanoma; MEL202, uveal melanoma.
doi:10.1371/journal.pone.0009685.g003
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atypical mirtrons were observed to have some degree of cross-
species sequence conservation. Figure 4 shows an example of
sequence conservation in a known atypical mirtron miRNA (hsa-
mir-1287) and a novel candidate atypical mirtron miRNA
(MELmiRNA_293).
Location of other miRs
Aside from the 8 novel atypical mirtrons, 196 others were found
more deeply embedded within an intron, 20 were found within an
exon, 17 were in a gene promoter, while the remainder were
intergenic (see Table S9 for details). The genomic mapping of the
known miRNAs can be found in Table S10. Of interest, some of
the miRs are found within genes of particular relevance to
melanoma biology, for example: TRPM1 [26,27].
Discussion
The sequenced libraries were selectively chosen as they
represented an array of different melanocytic subtypes ranging
from normal pigment cells (melanoblasts and melanocytes) to non-
UV exposed (acral, mucosal and uveal), intermittently UV-
exposed and chronically UV-exposed melanomas. We also
included a cell line derived from a giant congenital nevus.
Figure 3 shows sample unsupervised hierarchical clustering
(Pearson’s correlation) based on expression of all known and
predicted miRNAs. It is worthy of note that within this dendogram
the group of six cutaneous melanomas cluster together.
We note that the most highly ‘‘plastic’’ cell type included in this
study, i.e. melanoblasts, had the largest number of unique
sequence tags as well as the most known and predicted miRNAs,
Figure 4. Example of sequence conservation in a known miRNA (hsa-mir-1287) and a novel candidate miRNA (MELmiRNA_293).
doi:10.1371/journal.pone.0009685.g004
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least (Tables S1A and S1B, and Table 2). It is thus tempting to
speculate that the miRNA repertoire of a cell diminishes as it
terminally differentiates. The various melanoma samples (and the
nevocyte cell line) had intermediate numbers, consistent with the
notion that these tumor cells have undergone some de-differen-
tiation.
Our analyses of the sequence reads generated from the libraries
was relatively stringent with the requirement of reads having to be
present at least twice to be included. The removed single reads
accounted for up to 20% of some libraries. While it is likely that a
proportion of these single reads represent real miRNAs we set this
cut-off to filter out potential sequence errors. Another stringency
criterion was that each read had to map with no mismatches.
Again, some of the unmatched reads may represent new miRNAs
but the potential for clonal amplification of PCR-generated
artefacts meant that it was more prudent for these reads to be
eliminated. Additionally, as a function of depth of coverage, there
may be more extremely rare miRNAs to discover in these libraries,
albeit the likelihood of these having a significant impact on
melanocyte biology is relatively low.
The miRanalyzer software [20] proved to be a very useful tool
especially in categorising the sequence reads into different classes.
This was evident in the percent of reads that mapped to the
transcriptome. Due to their size it is nearly impossible to separate
mature miRNA transcripts from degraded mRNAs during library
preparation.
Recently, Linsen and colleagues [28] discussed the apparent
sequencing bias toward certain small RNAs thereby preventing the
accurate determination of their absolute numbers. Their paper
used the let-7 family as an example since they account for the
majority of the read counts observed. In the present study we have
also noted that let-7 family members were highly expressed across
all libraries and conclude that this is indeed a true reflection of
their relative abundance as the mRNA expression levels of some of
their known gene targets, the RAS family [29] and HMGA2 [30],
show an inverse correlation with read proportion and relative gene
expression (data not shown). A possible explanation for the very
high read count of the let-7s, in particular let-7a and let-7f, may be
because they are the master regulators of many genes involved in
cell proliferation [29] and as such they require an overall high level
of expression to exert an effect on each of their target genes.
The massively parallel sequencing of a diverse set of melanoma
and pigment cell libraries revealed a total of 539 known mature
and mature-star sequences along with the prediction of 279
candidate novel miRNAs, of which 109 were common to 2 or
more libraries, with 3 present in all libraries. This is a large
increase upon the number of published miRNAs currently in the
miRBase database. As a proof of principle we designed a custom
Taqman assay for one of the 3 miRNAs from the high confidence
list (MELmiRNA_677) that was present in all libraries. We were
able to confirm expression of MELmiRNA_677, which showed
strong correlation between relative sequence abundance and DCt
value (R
2=0.8). These data suggest that the prediction (miR-
analyzer) and filtering tools (CID-miRNA) we have employed can
yield high quality predictions.
Table S7 highlights that many of the novel candidates are of
quite high abundance in the libraries sequenced. This raises the
question of why these novel candidates haven’t been documented
before? The answer may in part be due to some of these miRNAs
being specific for the melanocytic lineage, or that many low
abundance miRNAs are only likely to be detected through next-
generation sequencing efforts. Screening of a large panel of
samples from different cell types would be useful to assess these
possibilities. Pigment cell specific miRNAs might be of benefit for
melanoma diagnosis and early detection of distant metastases and
disease recurrence by measuring the circulating levels of these
potential biomarkers in blood (reviewed in [31]). The primary
candidates we have identified so far that may satisfy this goal are
MELmiRNA_197, MELmiRNA_434, and MELmiRNA_677,
since they are present in all libraries. Moreover, candidate novel
miRNAs which appear unique to a particular library may also be
useful as histotype-specific markers, especially for identification of
metastatic tumors of unknown origin. A more extensive analysis of
a larger subset of samples of each melanoma histotype is required
to answer this question. It would also be appropriate to compare
miRNA profiles from uncultured melanomas and melanocytic
nevi with those presented here for purified pigment cells cultured
in vitro, since the in vivo microenvironment might alter the
relative abundance of some miRNAs, and conceivably condition
whether some miRNAs are expressed. However, in order to
overcome the obvious problem of tissue heterogeneity in fresh
tumor samples, such comparisons would require micro dissection
of the tumor cells. Indeed, even within a tumor there could be sub-
regional differences in miRNA profiles. Thus, to more compre-
hensively characterize the melanoma miRNAome, assessment of a
large number of melanomas at different stages of progression is
needed.
These data have also highlighted the importance of deep
sequencing to discover and quantify miRNAs rather than simply
relying on off-the-shelf microarrays that contain only a set of
known miRNAs. While such arrays are useful screening tools, they
do not allow for the discovery of novel candidates that may be
specific to a particular cell lineage or series of samples. Moreover,
they do not consider the expression of isomirs, some of which are
more abundant than the annotated mature miRNA. Many of the
miRNA microarrays constructed to date also lack the full
complement of miRNA star sequences. Taken together, deep
sequencing could be considered the gold standard for compre-
hensive analysis of the miRNAome.
Materials and Methods
Samples
Cell lines derived from melanoblasts (QF1160MB) and
melanocytes (MELB) were derived from non-UV exposed
neonatal foreskins [32]. A congenital giant nevus (MM653), an
acral melanoma (D10), a mucosal melanoma (D11), a primary
uveal melanoma (MEL202), a melanoma cell line derived from a
metastasis of a primary tumor occurring on a chronically sun
exposed body site (MM472), and various cell lines derived from
melanoma metastases arising from primary tumors occurring on
intermittently sun-exposed body sites (D20, MM386, MM426,
MM466, and MM603) were included in the library preparation.
Melanoblasts and melanocytes were established from neonatal
foreskin tissue and cultured in as described [32,33]. All tissue was
taken with informed consent under a protocol approved by the
Queensland Institute of Medical Research Human Research
Ethics Committee (HREC), approval number H0311-084 (P726).
All other cell lines were cultured as described in [34].
Total RNA extraction from cultured cells.
RNA was extracted from cultured cells using a miRNeasy Mini
kit (QIAGEN) as per the manufacturer’s instructions. This kit
combines phenol/guanidine-based lysis of samples and silica
membrane–based purification of total RNA which ensures no
impurities remain in the sample.
Melanoma miRNA Deep Sequencing
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The small RNA libraries were constructed using a Digital Gene
Expression (DGE) Small RNA sample prep kit (Illumina, San
Diego, Ca) as per the manufacturer’s instructions. Briefly, small
RNA was gel purified from 10 mg of total RNA, 59 and 39 adaptors
were ligated, followed by reverse transcription and library
enrichment by PCR amplification. Following enrichment, the
cDNA library was purified and validated for size, quality and
concentration using an Agilent Bioanalyzer 2100 (Agilent
Technologies, Santa Clara CA).
Cluster Generation and SBS sequencing
Each small RNA cDNA library was denatured with 2 N NaOH
to a final concentration of 0.5 nM. This was achieved by adding
1 ml of a 10 nM stock library along with 1 ml of 2 N NaOH and
18 ml of EB (QIAGEN). The denatured libraries were then diluted
in hybridization buffer to the desired pM concentration. Using an
Illumina Cluster Station, the diluted libraries were hybridized to
an 8-lane flow cell, followed by cluster generation by isothermal
amplification using a DGE-Small RNA Cluster Generation Kit
v1.0 (Illumina, San Diego, CA). The prepared flowcell was then
subjected to sequencing by synthesis (version 1.0) using a Genome
Analyzer II, according to the manufacturer’s instructions.
Data Analysis
Following the completed sequencing runs the images were
analysed using the Illumina Pipeline v1.3.2 software suite
(GOAT). Firstly the images were analysed using Firecrest, which
identifies clusters based on morphological features on the image
and sharpens them through image filtering, removes background
noise and extracts their intensities. Following image analysis bases
were called using the program Bustard, which deconvolutes the
signal from the clusters and applies correction for cross-talk,
phasing, and prephasing (see Illumina Pipeline v1.3.2 software
manual for detail). Sequence reads were then aligned to the hg18
genome using the program Eland and analysed for miRNA
content using the miRanalyzer web server tool (http://web.
bioinformatics.cicbiogune.es/miRNA) [20]. All data is MIAME
compliant and has been deposited in GEO (www.ncbi.nlm.nih.
gov/geo) (accession number GSE18381). Briefly, a perl script
scans through all of the sequence outputs and assigns a copy
number for each unique read. This simple input file (GSE18381)
is then submitted to the webserver where it records matches to
miRNAs annotated in miRBase [23], as well as perfect matches
to the transcriptome. The algorithm also predicts any novel
miRNAs that are present within the sequence input. In order to
obtain robust data we limited the unique sequence reads fed into
this algorithm to those that occurred 2 or more times. Perfect
alignment with no mismatches were also part of the criteria.
There is no need to remove any partial adaptor sequence from
the sequence reads as the algorithm automatically trims this
before alignment. The predicted novel miRNA candidates were
filtered further by using CID-miRNA [21], a tool for identifica-
tion of miRNA precursors in a given DNA sequence (http://
mirna.jnu.ac.in/cidmirna). This algorithm utilises a probabilistic
model based on stochastic context free grammar and secondary
structure-based filtering systems (SCFG). CID-miRNA can be
used as a command-line tool or through a web interface to
analyse genomic sequences for the presence of possible pre-
miRNA regions in the genome. This secondary analysis of the
miRanalyzer predictions allowed for more confidence in the
assignment of candidate pre-miRNAs.
The known and predicted novel candidate miRNAs were
mapped to the genome following the miRanalyzer and CID-
miRNA analysis. This analysis was performed to detect the
presence of mirtrons. We developed a perl based pipeline to map
the miRNA tags on to the known gene structures in the human
genome. We used the hg18 version of human genome to extract
the latest annotation. The genome coordinates for the miR-tags
were obtained using miRanalyzer [20]. The transcript and coding
region start and end coordinates from the hg18 annotation were
used to determine the 59UTR and 39UTRs on the fly. The exon
and intron coordinates were used as indicated in the annotation.
Non-coding genes were also considered while mapping the miR-
tags to the genome. A source code for this pipeline can be obtained
by writing to the authors.
Real-Time PCR confirmation
Novel predicted miRNAs were confirmed via a custom small
RNA Taqman assay (Applied Biosystems). Firstly 10 ng of total
RNA were reverse transcribed into cDNA using the miRNA-
specific primer. From the same total RNA sample an endogenous
control gene (RNU48) was also assayed. qRT-PCR was then
performed in triplicate using a Rotorgene 6000 (QIAGEN) with
the PCR products being amplified from the cDNA samples using
the Taqman miRNA assay together with the Taqman Universal
PCR Master Mix (Applied Biosystems). The DDCT method was
used to analyze the expression values.
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